Differences in Hospital-Associated Multidrug-Resistant Organisms and Clostridium difficile Rates Using 2-Day versus 3-Day Definitions

Differences in Hospital-Associated Multidrug-Resistant Organisms and Clostridium difficile Rates Using 2-Day versus 3-Day Definitions

We surveyed infection prevention programs in 16 hospitals for hospital-associated methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci, extended-spectrum β-lactamase, and multidrug-resistant Acinetobacter acquisition, as well as hospital-associated MRSA bacteremia and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Infection control and hospital epidemiology 2014-11, Vol.35 (11), p.1417-1420
Hauptverfasser: Gombosev, Adrijana, Fouad, Salah E., Cui, Eric, Cao, Chenghua, Terpstra, Leah, Avery, Taliser R., Kim, Diane, Meyers, Hildy, Cheung, Michele, Huang, Susan S.
Format: Artikel
Sprache:eng
Schlagworte:
Acinetobacter
Acinetobacter Infections - diagnosis
Acinetobacter Infections - epidemiology
Bacteremia
Bacteremia - diagnosis
Bacteremia - epidemiology
Bacteremia - microbiology
beta-Lactam Resistance
California
Carrier State - diagnosis
Carrier State - epidemiology
Carrier State - microbiology
Clostridium difficile
Concise Communication
Cross Infection - diagnosis
Cross Infection - epidemiology
Cross Infection - microbiology
Data acquisition
Drug Resistance, Multiple, Bacterial
Enterocolitis, Pseudomembranous - diagnosis
Enterocolitis, Pseudomembranous - epidemiology
Enterocolitis, Pseudomembranous - microbiology
Hospital admissions
Humans
Infections
Methicillin resistant staphylococcus aureus
Nursing
Practice Guidelines as Topic
Prospective Studies
Staphylococcal Infections - diagnosis
Staphylococcal Infections - epidemiology
Staphylococcal Infections - microbiology
Staphylococcus aureus
Statistical median
Surveillance
Time Factors
Vancomycin-Resistant Enterococci
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We surveyed infection prevention programs in 16 hospitals for hospital-associated methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci, extended-spectrum β-lactamase, and multidrug-resistant Acinetobacter acquisition, as well as hospital-associated MRSA bacteremia and Clostridium difficile infection based on defining events as occurring >2 days versus >3 days after admission. The former resulted in significantly higher median rates, ranging from 6.76% to 45.07% higher.
ISSN:0899-823X
1559-6834
DOI:10.1086/678423